Pfizer/Eisai's Aricept Covered By 40 Out Of 130 U.K. Authorities
Executive Summary
Less than one-third of the U.K.' s local health authorities are reimbursing or considering reimbursing Pfizer/Eisai's Alzheimer's disease therapy Aricept (donepezil), a British pharmaceutical industry report states.